Pouneh Fazeli, MD
Enriched profileChief, Division of Endocrinology and Metabolism, and Professor of Medicine · University of Pittsburgh School of Medicine
Pouneh Fazeli is Chief, Division of Endocrinology and Metabolism, and Professor of Medicine at University of Pittsburgh School of Medicine. OpenAlex indexes 154 publications with 5,822 citations (h-index 39); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 15 Oct 2026
Overview
Updated 16 Oct 2026
Pouneh Fazeli, MD, is Chief, Division of Endocrinology and Metabolism, and Professor of Medicine at University of Pittsburgh School of Medicine. The public record shows 154 publications with 5,822 citations (h-index 39), centered on Bone health and osteoporosis research, Pituitary Gland Disorders and Treatments, Eating Disorders and Behaviors. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 5 companies, 2 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · Climacteric
- Top research focus: Bone health and osteoporosis research
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 69.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- The Metabolic Effects of Intermittent Fasting
Sponsor: University of Pittsburgh
- Transdermal Estrogen in Women With Anorexia Nervosa
Sponsor: Pouneh K. Fazeli, MD
- Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa
Sponsor: Massachusetts General Hospital
Industry payments
Updated 16 Oct 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20252 payments
- Regeneron Pharmaceuticals, Inc.Program year20253 payments
- Amgen Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
59.6%l-Thyroxine51%Levothyroxine Sodium82%Synthroid18%Part D<11 patientsVasopressin Analog8.6%Desmopressin Acetate100%Part D<11 patientsSensory organs
19.2%Corticosteroid19.2%Hydrocortisone84%Dexamethasone Sodium Phosphate16%Part D<11 patientsGenitourinary & hormones
8.1%Androgen8.1%Testosterone Cypionate52%Testosterone48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Beneficial reprogramming of lipid metabolism with intermittent fasting
University of Pittsburgh at Pittsburgh
FY2026$666,071R01DK133578 - Beneficial reprogramming of lipid metabolism with intermittent fasting
University of Pittsburgh at Pittsburgh
FY2025$666,071R01DK133578 - Beneficial reprogramming of lipid metabolism with intermittent fasting
University of Pittsburgh at Pittsburgh
FY2024$663,984R01DK133578
Congress activity
Updated 16 Oct 2026
14 congress contributions (2019–2025) across ENDO per OpenAlex. The most recent:
- MON-088 Effects Of Relacorilant On Pituitary Tumor Volume In Patients With Cushing Disease: Results From The Phase 3 Grace Study
ENDO Annual Meeting
ENDO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- MEN4 variant of unknown significance in two generations of patients presenting with Cushing disease.
JCEM case reports
Case Report2026 - Subclinically low BMD in young men is associated with compromised bone microarchitecture and lower lean mass.
Journal of the Endocrine Society
Article2026 - Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial.
Osteoporosis international
Clinical Trial2026 - A Critical Assessment of Fasting to Promote Metabolic Health and Longevity.
Endocrine reviews
Review2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Marrow Fat and Bone—New PerspectivesArticle417 citations2013
- 04Increased Bone Marrow Fat in Anorexia NervosaArticle385 citations2009
- 05FGF21 and the late adaptive response to starvation in humansArticle212 citations2015
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/pouneh-fazeli-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
news.dom.pitt.edu
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.dom.pitt.edu ↗ - Other
pituitary.org/highlights-enewsletter/pna-spotlight-pouneh-fazeli
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pituitary.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Pennsylvania School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upmcphysicianresources.com ↗ - MPH
Harvard School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upmcphysicianresources.com ↗
Secondary affiliations
appointments beyond the home institution- UPMC Pituitary Center of Excellence (Medical Director); Director
Neuroendocrinology Unit
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upmcphysicianresources.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upmcphysicianresources.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Adam Brufsky, MD, PhD
University of Pittsburgh School of Medicine
Paul Palevsky, MD
University of Pittsburgh School of Medicine
Daniel Kaplan, MD, PhD
University of Pittsburgh School of Medicine
Tharick Pascoal, MD
University of Pittsburgh School of Medicine
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine